Our analysis of the Cancer Genome Atlas (TCGA) cohort to assess the association of ZNF469 mutations with a prognosis in pan-cancer showed a higher ZNF469 expression and a poorer clinical prognosis in samples with ZNF469 mutations (Figure 5F,G). The gene discussed is ZNF469; the disease is cancer.